dr. bourhis on the rationale to explore debio 1143 in head and neck cancer
Published 4 years ago • 125 plays • Length 1:46Download video MP4
Download video MP3
Similar videos
-
2:39
jean bourhis, esmo 2019 - debio 1143 in head and neck cancer
-
1:08
dr. bourhis on results of the phase ii trial with debio 1143 in head and neck cancer
-
1:57
dr. burtness on the future of immunotherapy in head and neck cancer
-
1:01
crt and debio1143 for treatment of la scchn
-
1:49
dr. saba discusses ongoing research in head and neck cancer
-
1:52
dr. burtness on the development of immunotherapy in head and neck cancers
-
0:57
dr. brose on the fact2 study and the treatment of anaplastic thyroid cancer
-
0:33
onclive news network preview: fda approval in head and neck cancer
-
1:26
dr. rugo on rationale for the elaine study in esr1-mutated er /her2- breast cancer
-
1:07
dr. bouvet discusses the diagnosis of thyroid cancer
-
1:00
dr. bouvet discusses risk factors for thyroid cancer
-
0:59
dr. schlumberger draws conclusions from the select trial in thyroid cancer
-
6:15
osler weber rendu syndrome
-
2:39
ep #6 - what recipes/foods from this diet should cancer patients consume?
-
3:06
prof. l. wirth - advanced differentiated thyroid cancer
-
1:18
dr. marcia brose on sorafenib in radioactive iodine-resistant thyroid cancer
-
1:19
hereditary breast and ovarian cancer syndrome (hboc)
-
1:12:38
the ins and outs of a seemingly easy cancer—thyroid cancer
-
5:26
piercing the cell